COMSCORE, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COMSCORE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $403.55M | Mar 23, 2018 |
| FY2017 | Dec 31, 2016 | $399.46M | Mar 23, 2018 |
| FY2017 | Dec 31, 2015 | $270.80M | Mar 23, 2018 |
| FY2014 | Dec 31, 2014 | $329.15M | Feb 20, 2015 |
| FY2014 | Dec 31, 2013 | $286.86M | Feb 20, 2015 |
| FY2014 | Dec 31, 2012 | $255.19M | Feb 20, 2015 |
| FY2013 | Dec 31, 2011 | $232.39M | Feb 18, 2014 |
| FY2012 | Dec 31, 2010 | $175.00M | Feb 20, 2013 |
| FY2011 | Dec 31, 2009 | $127.74M | Feb 22, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $357.47M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $356.05M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $371.34M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $376.42M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $367.01M | Mar 12, 2024 |
| FY2020 | Dec 31, 2020 | $89.99M | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | $87.95M | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | $88.57M | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | $89.53M | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | $95.16M | Mar 10, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $46.49M | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | $41.49M | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | $43.62M | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | $43.73M | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | $48.33M | Mar 10, 2021 |
| FY2020 | Sep 30, 2019 | $46.91M | Mar 10, 2021 |
| FY2020 | Jun 30, 2019 | $44.89M | Mar 10, 2021 |
| FY2020 | Mar 31, 2019 | $48.89M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $57.32M | Feb 28, 2020 |
| FY2019 | Sep 30, 2018 | $53.42M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.00M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($60.25M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | ($79.36M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | ($66.56M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | ($50.04M) | Mar 12, 2024 |
| FY2020 | Dec 31, 2020 | ($13.21M) | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | ($11.12M) | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | ($10.40M) | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | ($13.18M) | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | ($21.39M) | Mar 10, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.51M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($59.51M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | ($73.60M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | ($74.87M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | ($28.87M) | Mar 12, 2024 |
| FY2020 | Dec 31, 2020 | ($1.75M) | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | ($4.03M) | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | ($2.74M) | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | ($12.75M) | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | ($5.91M) | Mar 10, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.17M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $33.07M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $33.70M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $36.99M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $39.12M | Mar 12, 2024 |
| FY2020 | Dec 31, 2020 | $9.30M | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | $9.50M | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | $9.77M | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | $10.14M | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | $12.64M | Mar 10, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.74M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $18.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $28.93M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $34.94M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $9.86M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $717.0K | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | ($4.64M) | Mar 2, 2022 |
| FY2020 | Dec 31, 2018 | ($72.58M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | ($56.41M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | ($55.91M) | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $956.0K | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $813.0K | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.58M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.14M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $803.0K | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $477.0K | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $2.74M | Mar 2, 2022 |
| FY2020 | Dec 31, 2018 | $4.21M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $10.18M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $7.11M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $407.71M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $430.25M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $491.30M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $580.59M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $663.47M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $677.97M | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | $723.70M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $954.14M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.02B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.12B | Mar 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $206.55M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $231.04M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $247.31M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $248.54M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $252.41M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $448.98M | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | $464.72M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $402.58M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $365.95M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $215.94M | Mar 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111.44M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($8.26M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $56.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2022 | $144.16M | Mar 26, 2026 |
| FY2024 | Dec 31, 2021 | $223.18M | Mar 6, 2025 |
| FY2023 | Dec 31, 2020 | $228.99M | Mar 12, 2024 |
| FY2022 | Dec 31, 2019 | $258.97M | Mar 2, 2023 |
| FY2019 | Jan 1, 2019 | $551.52M | Feb 28, 2020 |
| FY2021 | Dec 31, 2018 | $551.57M | Mar 2, 2022 |
| FY2018 | Jan 1, 2018 | $655.76M | Mar 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $248.64M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $246.01M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $310.36M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $387.97M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $435.71M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $418.33M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $416.42M | Mar 2, 2022 |
| FY2020 | Dec 31, 2018 | $641.19M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $642.42M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $639.90M | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.43B) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($1.47B) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($1.40B) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($1.30B) | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | ($1.22B) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($1.16B) | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | ($1.11B) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($769.10M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($609.09M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($327.70M) | Mar 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.62M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $29.94M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $22.75M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $20.04M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $21.85M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $31.13M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $46.59M | Mar 2, 2022 |
| FY2020 | Dec 31, 2018 | $44.10M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $37.86M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $84.11M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.55M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $41.17M | Mar 26, 2026 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (15) | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | (19) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | (17) | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | (15) | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | (5) | Mar 2, 2022 |
| FY2017 | Dec 31, 2017 | (1) | Mar 23, 2018 |
| FY2017 | Sep 30, 2017 | (2) | Mar 23, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Mar 23, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (15) | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | (19) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | (17) | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | (15) | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | (5) | Mar 2, 2022 |
| FY2017 | Dec 31, 2017 | (1) | Mar 23, 2018 |
| FY2017 | Sep 30, 2017 | (2) | Mar 23, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Mar 23, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.88M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 4.89M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 4.76M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 4.61M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | 90.41M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | 72.94M | Mar 2, 2022 |
| FY2020 | Dec 31, 2019 | 70.07M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | 59.39M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 57.29M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 57.17M | Mar 23, 2018 |